’s Nest, a healthtech pitch competition, last November. Biotechnology company POEM has developed a drug discovery platform called POEM which aims to help pharmaceutical companies create new drug-like compounds using a genetic algorithm and AI-based Cyclica technology. President and CEO of the Cyclica start-up John Conway said the company is looking to reduce the drug discovery timescale from seven years to two years .
Biotechnology company POEM has developed a drug discovery platform called POEM which aims to help pharmaceutical companies create new drug-like compounds using a genetic algorithm and AI-based Cyclica technology. President and CEO of the Cyclica start-up John Conway said the company is looking to reduce the drug discovery timescale from seven years to two years .